Assistive technology for people with amyotrophic lateral sclerosis in Japan: Present status, analysis of problem and proposal for the future

2001 ◽  
Vol 13 (1) ◽  
pp. 9-15
Author(s):  
Takuro Hatakeyama ◽  
Akira Okamoto ◽  
Kazuo Kamata ◽  
Masao Kasuga
Author(s):  
Thais Pousada ◽  
Jessica Garabal-Barbeira ◽  
Cristina Martínez ◽  
Betania Groba ◽  
Laura Nieto-Riveiro ◽  
...  

(1) Background: The study is focused on the implementation of outcome measurement tools to assess the impact of an assistive device from a loan bank in the lives of people with Amyotrophic Lateral Sclerosis and Neuromuscular Diseases. The secondary purpose is to analyse the correct matching between the person and technology, derived from the counselling of an occupational therapist. (2) Methods: Cross-sectional study. The sample was formed by 28 people with rare neurodegenerative disorders. A specific questionnaire, the Psychosocial Impact of Assistive Device Scale (PIADS), and the Matching Person and Technology (MPT) tool were applied to collect the data. (3) Results: The dimension of the PIADS with the best score was competence, and the variations according to gender were not remarkable. The three dimensions of the PIADS (competence, adaptability, and self-esteem) were correlated positively between them and with the mean score of the MPT tool (p < 0.01). The type of assistive technology (AT), diagnosis, and correct match between person–technology are the main factors that condition a positive impact. (4) Conclusions: The results noted the importance of assessing the needs, demands, and contexts of people with rare neurodegenerative diseases to prescribe the best AT. Loan banks of AT have to be considered a valid service that complements their lack in public health services.


1929 ◽  
Vol 25 (9) ◽  
pp. 966-968
Author(s):  
I. В. Grossman

Amyotrophic lateral sclerosis, described for the first time in 1869 - 1874 by Charcot and Joffrois and which received more accurate and complete coverage in the future thanks to the studies of Flсhsig, is known to be characterized by primary systemic degeneration along the cortical-muscular pathway, including here, in addition to the spinal cord department, and bulbar, related to the muscles of the face, tongue, soft palate, etc.; the entire conductive path is not always captured, but only a significant part of it


2015 ◽  
Vol 5 (2) ◽  
pp. 93-95 ◽  
Author(s):  
Yoshitsugu Aoki ◽  
Andrew GL Douglas ◽  
Matthew JA Wood

2011 ◽  
Vol 43 (5) ◽  
pp. 643-647 ◽  
Author(s):  
Kirsten L. Gruis ◽  
Patricia A. Wren ◽  
Jane E. Huggins

2021 ◽  
Vol 11 (12) ◽  
pp. 1597
Author(s):  
Remko M. van Eenennaam ◽  
Loulou S. Koppenol ◽  
Willeke J. Kruithof ◽  
Esther T. Kruitwagen-van Reenen ◽  
Sotice Pieters ◽  
...  

The ENCALS survival prediction model offers patients with amyotrophic lateral sclerosis (ALS) the opportunity to receive a personalized prognosis of survival at the time of diagnosis. We explored experiences of patients with ALS, caregivers, and physicians with discussing personalized prognosis through interviews with patients and their caregivers, and in a focus group of physicians. Thematic analysis revealed four themes with seven subthemes; these were recognized by the focus group. First, tailored communication: physician’s communication style and information provision mediated emotional impact and increased satisfaction with communication. Second, personal factors: coping style, illness experiences, and information needs affected patient and caregiver coping with the prognosis. Third, emotional impact ranged from happy and reassuring to regret. Fourth, regaining control over the future: participants found it helpful in looking towards the future, and emphasized the importance of quality over quantity of life. Personalized prognosis can be discussed with minimal adverse emotional impact. How it is communicated—i.e., tailored to individual needs—is as important as what is communicated—i.e., a good or poor prognosis. Discussing personalized prognosis may help patients with ALS and their caregivers regain control over the future and facilitate planning of the future (care). For many patients, quality of life matters more than quantity of time remaining.


2004 ◽  
Vol 1 (1) ◽  
pp. 13-21 ◽  
Author(s):  
DAVID W. MILLER ◽  
MARK R. COOKSON ◽  
DENNIS W. DICKSON

In this review, we discuss examples that show how glial-cell pathology is increasingly recognized in several neurodegenerative diseases. We also discuss the more provocative idea that some of the disorders that are currently considered to be neurodegenerative diseases might, in fact, be due to primary abnormalities in glia. Although the mechanism of glial pathology (i.e. modulating glutamate excitotoxicity) might be better established for amyotrophic lateral sclerosis (ALS), a role for neuronal–glial interactions in the pathogenesis of most neurodegenerative diseases is plausible. This burgeoning area of neuroscience will receive much attention in the future and it is expected that further understanding of basic neuronal–glial interactions will have a significant impact on the understanding of the fundamental nature of human neurodegenerative disorders.


Sign in / Sign up

Export Citation Format

Share Document